SGLT-2 Inhibitors Tied to Less Death, HF, MI, Stroke: CVD REAL 2 SGLT-2 Inhibitors Tied to Less Death, HF, MI, Stroke: CVD REAL 2

Data continue to indicate that use of SGLT-2 inhibitors in clinical practice is associated with a lower risk for cardiovascular events across the board, now in a more diverse population, a finding researchers call reassuring.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news